Acronym ResisT
Category
Marine Biotechnology
Title Sting-free vaccination with recombinant proteins and tissue-modulating probiotics for improved immunity and protection against tenacibaculosis in Atlantic salmon Programme National Programme
Instrument (FP6)
Contact Type (FP7)
Strand (Interreg)
NA
Theme (FP7)
Activity Area (FP6)
Regional Area (Interreg)
Action (COST)
NA
Specific Programme (FP7)
NA
Funding source National Coordinator Christian Renè Karlsen Coordinator email christian.karlsen@nofima.no
Coordinator institution
NOFIMA - Norwegian Institute of Food, Fisheries and Aquaculture Research (Norway)
Institutions involved
NA - Cermaq Norway AS (Norway) ,
NA - Marin Helse AS (Norway) ,
NA - PHARMAQ Analytiq AS
(Norway) ,
Start year 2021 End year 2022 Funding (€) € 299,266 Website https://www.fhf.no/prosjekter/prosjektbasen/901655/ Summary Wound development caused by bacterial infections in the sea is a challenge in Norwegian salmon farming. Skin problems associated with the bacteria Moritella viscosa (winter sores) and Tenacibaculum spp. (tenacibaculosis) are the biggest cause for concern. In recent years, Tenacibaculum finnmarkense has been a growing problem in northern Norway. Outbreaks of tenacibaculosis result in losses, often through the transfer of smolts to seawater. There is no effective vaccine against tenacibaculosis in salmonids. The aim of this project is to investigate whether recombinant antigen proteins in combination with probiotics will result in protection against T. finnmarkense . This will represent important measures that can improve biosecurity related to ulcer disease in the salmon industry.
Main objective:
Investigate the effect of antigenic proteins and probiotics or their combination against the development of skin ulcers caused by T. finnmarkense.
Sub-goals:
• To expand the characterization of the antigens and variation in Tenacibaculum.
• To identify immune responses and best model for vaccination.
• To test the degree of protection against T. finnmarkense.
Keywords
Open sea aquaculture;
Cage aquaculture;
Animal welfare;
Disease;
Vaccines development;
Bioprospecting;
Salmon;
Fish;
Fish health;
Bacteria;
Marine Region
76
Not associated to marine areas
0
Marine Region Map
